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The Apicomplexa-specific 
glucosamine-6-phosphate N-
acetyltransferase gene family 
encodes a key enzyme for 
glycoconjugate synthesis with 
potential as therapeutic target
Marta Cova  1, Borja López-Gutiérrez  1, Sara Artigas-Jerónimo1, Aida González-Díaz1,  
Giulia Bandini2, Steven Maere  3,4,5, Lorenzo Carretero-Paulet3,4,5 & Luis Izquierdo  1
Apicomplexa form a phylum of obligate parasitic protozoa of great clinical and veterinary importance. 
These parasites synthesize glycoconjugates for their survival and infectivity, but the enzymatic steps 
required to generate the glycosylation precursors are not completely characterized. In particular, 
glucosamine-phosphate N-acetyltransferase (GNA1) activity, needed to produce the essential UDP-
N-acetylglucosamine (UDP-GlcNAc) donor, has not been identified in any Apicomplexa. We scanned 
the genomes of Plasmodium falciparum and representatives from six additional main lineages of the 
phylum for proteins containing the Gcn5-related N-acetyltransferase (GNAT) domain. One family of 
GNAT-domain containing proteins, composed by a P. falciparum sequence and its six apicomplexan 
orthologs, rescued the growth of a yeast temperature-sensitive GNA1 mutant. Heterologous expression 
and in vitro assays confirmed the GNA1 enzymatic activity in all lineages. Sequence, phylogenetic and 
synteny analyses suggest an independent origin of the Apicomplexa-specific GNA1 family, parallel 
to the evolution of a different GNA1 family in other eukaryotes. The inability to disrupt an otherwise 
modifiable gene target suggests that the enzyme is essential for P. falciparum growth. The relevance 
of UDP-GlcNAc for parasite viability, together with the independent evolution and unique sequence 
features of Apicomplexa GNA1, highlights the potential of this enzyme as a selective therapeutic target 
against apicomplexans.
Apicomplexa form one of the largest and most diverse phyla of obligate intracellular parasites in the protist king-
dom. They exhibit a fascinating biology, featuring (i) a specialized set of microtubules at the apical end of the 
cell, (ii) plastid-derived organelle called apicoplast, lost in some lineages, and (iii) a wide variety of morphologies 
and complex life cycles, consistent with the ability to infect almost every kind of animal from mollusks to mam-
mals1. Although it has been estimated that between 1.2 and 10 million species exist2, only about 5,000–6,000 
have been identified to date1, including species of clinical importance. Plasmodium species, for example, cause 
malaria, a disease responsible for more than 200 million new cases and 445,000 deaths in 20163. Toxoplasmosis, 
caused by the ubiquitous human pathogen Toxoplasma gondii, contributes to congenital disease and opportun-
istic infections in immunocompromised persons4. Cryptosporidium parvum is responsible for cryptosporidiosis, 
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the second leading cause of diarrheal disease in infants in developing countries5. Other Apicomplexa species are 
also very relevant to food security and veterinary medicine, since organisms like Babesia or Theileria spp. infect 
cattle, and Eimeria spp. infects poultry, producing severe economic losses every year6,7. Furthermore, their hosts 
are not restricted to vertebrates, as in Gregarina niphandrodes, which commonly infects beetles8. However, despite 
the global economic burden and major human health problems caused by Apicomplexa, many aspects of their 
biology and host interaction are still unknown. Some of the reasons that may be hindering the characterization 
of specific biochemical pathways in these organisms are possibly linked to their evolutionary transition from a 
free-living to an obligate parasitic lifestyle, including (i) the massive loss of genes involved in diverse metabolic 
processes9, and (ii) their ability to scavenge metabolite precursors from their hosts10.
Glycoconjugates cover the surface of many protozoan parasites, forming protective barriers and mediating 
host-pathogen interactions11. Glycosylphosphatidylinositol (GPI) anchors, attached to the C-terminus of proteins 
to anchor them to cell membranes, are the major glycan moieties identified on the surface of P. falciparum and 
other Apicomplexa12,13. GPI anchors are composed of a conserved glycan backbone linked to a myo-inositol ring 
of phosphatidylinositol (PI)14. GPI synthesis involves the initial transfer of N-acetylglucosamine (GlcNAc) from 
the UDP-GlcNAc donor to the PI acceptor followed by GlcNAc de-acetylation15. Apicomplexa also N-glycosylate 
proteins in the endoplasmic reticulum16,17, in a process that requires GlcNAc transfer from UDP-GlcNAc to 
dolichol phosphate (Dol-P) to generate the core lipid-linked oligosaccharide precursor. Both GPI biosynthesis 
and N-glycosylation are highly conserved processes critical for eukaryotic cell viability18–21. UDP-GlcNAc is also 
donor for the nucleocytosolic O-GlcNAc transferase, characterized in C. parvum22, and it serves as intermediate 
for the generation of UDP-N-acetylgalactosamine, required for the O-glycosylation of mucin-like domains in C. 
parvum and T. gondii23,24. Due to the importance of this precursor, blocking UDP-GlcNAc biosynthesis leads to 
growth arrest, or non-viable phenotypes, in species as diverse as Trypanosoma brucei, Arabidopsis thaliana and 
yeast25–28. This suggests that the UDP-GlcNAc metabolic route is essential and, therefore, a potential target for 
selective inhibitors.
UDP-GlcNAc biosynthesis requires the acetylation of the GlcN-6P precursor to generate GlcNAc-6P (Fig. 1)29. 
This enzymatic step is catalyzed by a glucosamine-phosphate-N-acetyltransferase (GNA1) activity. GNA1 belongs 
to the large superfamily of Gcn5-N-acetyltransferase domain (GNAT)-containing proteins, grouping different 
families of enzymes that use acetyl coenzyme A (AcCoA) to transfer an acetyl group to a substrate30,31. Although 
highly divergent at the sequence level, GNAT proteins are well-conserved in structure and catalytic mecha-
nism26,32,33 and GNA1 enzymes have been identified and characterized throughout the eukaryote kingdom26,27,33. 
However, the identification of GNA1 in the genome of P. falciparum, or any other apicomplexan, has remained 
elusive29 despite the fact that the presence of UDP-GlcNAc was verified in different parasite stages34–36.
Here we identify GNA1 in P. falciparum and six other species representing main lineages of the phylum 
Apicomplexa. GNA1 forms a specific gene family with an evolutionary origin at least as ancient as the phylum. 
The independent evolution and unique sequence features of this enzyme, which we show is likely essential for 
parasite growth, highlight GNA1 as a potential pan-apicomplexan drug target amenable to selective inhibition.
Results
Classification of the superfamily of GNAT-domain containing proteins in Apicomplexa. To 
identify apicomplexan proteins presenting a GNAT domain, we searched the genomes of P. falciparum and 6 
additional species, representing the main lineages of the phylum, for sequences containing the INTERPRO 
protein functional domain IPR000182 (GNAT domain). 71 protein sequences were detected, belonging to 18 
orthogroups plus one singleton in the EupathDB database (http://eupathdb.org/eupathdb/, Supplementary 
Tables S1 and S2). In order to reconstruct the evolutionary relationships between these sequences, we performed 
phylogenetic analyses using three alternative methods (see Methods). 9 out of the 18 orthogroups, encompass-
ing 48 out of the 71 sequences, were retrieved by all three methods as well-supported clades in the tree (Fig. 2). 
Despite the overall high degree of divergence in terms of sequence composition and length, the protein domain 
architecture within each of these 9 clades appeared relatively well-conserved. Many of the non-GNAT domains 
in these clades matched INTERPRO protein functional domains generically associated to the GNAT domain, 
such as the Acyl-CoA N-acyltransferase domain, or associated to specific families of GNAT proteins, such as 
N-myristoyltransferases (NMT) or histone acetyltransferases (HAT) (Supplementary Table S3). The remaining 9 
orthogroups, clustering 23 out of 71 sequences, were not properly resolved in our phylogenetic analyses. A pos-
sible reason for this may be related to the unusually long branches recovered for some T. gondii sequences, which 
may lead to unexpected clustering in the tree37. T. gondii showed 15 GNAT-domain containing proteins compared 
Figure 1. Biosynthesis of UDP-GlcNAc in Apicomplexa. Fru6P, Fructose-6-phosphate; Glc6P, Glucose-6-
phosphate; G6PI, Glucose-6-phosphate isomerase (Enzyme Commission (EC) 5.3.1.9); GFPT, Glucosamine-
fructose-6-phosphate aminotransferase (EC 2.6.1.16); GNA1, Glucosamine-phosphate-N-acetyltransferase (EC 
2.3.1.4); HK, Hexokinase (EC 2.7.1.1); PAGM, Phosphoacetylglucosamine mutase (EC 5.4.2.3); UAP, UDP-N-
acetylglucosamine pyrophosphorylase (EC 2.7.7.23). The reaction catalyzed by the GNA1 enzyme is marked 
with a red box.
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to 9–11 in the remaining species, likely resulting from lineage-specific gene duplications (Fig. 2; Supplementary 
Table S1).
Identification of the GNA1 family in Apicomplexa. In yeast and other eukaryotic organisms, the 
glucosamine-6-phosphate acetyltransferase activity is known to be essential and encoded by GNA1, a specific 
family of GNAT proteins26,27,33. The evolutionarily conserved GNA1 gene family typically encodes proteins of 
150–200 aa length and only displays the GNAT and/or Acyl-CoA N-acyltransferase domains32. Out of the ten 
P. falciparum GNAT sequences, five were discarded as candidate GNA1s as they also contained protein domains 
corresponding to specific families of GNAT proteins other than GNA1. The remaining five (Fig. 2) were selected 
as candidate sequences and assayed for their putative GNA1 activity.
The five selected P. falciparum candidate sequences and Trypanosoma brucei GNA1 (TbGNA1)26 were 
cloned into the pRS421 pt plasmid and used to transform the S. cerevisiae GNA1 thermosensitive (ScGNA1-ts) 
mutant38. Only PF3D7_0629000 and TbGNA1 could support yeast growth in the absence of endogenous GNA1 
at 37 °C (Fig. 3A), and we consequently renamed PF3D7_0629000 as PfGNA1. Our phylogenetic analyses (Fig. 2) 
clustered PfGNA1 together with six additional sequences within a robustly supported clade corresponding to 
Figure 2. Phylogeny, protein domain architecture and taxonomic distribution of 71 GNAT proteins from seven 
apicomplexan species. The maximum-likelihood unrooted phylogenetic tree is drawn to scale, with branch 
lengths proportional to evolutionary distances between nodes. Branches leading to extant nodes in the tree are 
colored according to the species. Indicated in bold are sequences examined for GNA1 activity. Values next to 
the orthogroup-defining nodes indicate statistical support from maximum-likelihood, Bayesian and neighbor-
joining phylogenetic analysis, respectively. For EupathDB orthogroups retrieved as well-supported clades in the 
tree, colored strips indicate their taxonomic distribution (top right legend: Api, Apicomplexa; Euk, Eukaryota; 
Eug, Euglenozoa; Ubi, ubiquitous; Bab, Babesia; The, Theileria; Fun, Fungi; Tox, Toxoplasma; Eim, Eimeria). 
The apicomplexan-specific GNA1 family is enclosed within a continuous line box, while the HAT and the NMT 
families are enclosed within a dashed line box. A schematic protein architecture delineating the occurrence 
of conserved motifs detected using MEME is shown next to each protein (see Table S2). The distance between 
vertical lines on the right is 200 amino acids.
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orthogroup OG5_147324. The predicted orthologs to PfGNA1 from Babesia bovis, C. parvum, Eimeria tenella, T. 
gondii, Theileria annulata, and G. niphandrodes were also cloned in pRS421 pt and functional complementation 
assays were performed. All orthologous sequences were able to rescue the ScGNA1-ts mutant at 37 °C (Fig. 3B).
Independent evolutionary origin of the Apicomplexa-specific GNA1 family. According to the 
OrthoMCLDB database, of all orthogroups grouping Apicomplexa GNAT proteins, only OG5_144531 and 
OG5_147324 (Apicomplexa GNA1 family) showed a taxonomic distribution restricted to apicomplexan organ-
isms (Supplementary Table S2), suggesting their independent evolutionary origin within the phylum. In order to 
examine whether this represents an unusual feature of the Apicomplexa GNA1 family, we used the information 
provided by OrthoMCLDB to look at the taxonomic distribution of 30 P. falciparum29,34 enzymes involved in 
sugar nucleotide biosynthesis and related pathways across 150 species representing 12 eukaryote and prokar-
yote lineages (Fig. 4A, Supplementary Table S4). For each associated orthogroup, we plotted as a heat map 
the fraction of species within each taxonomic lineage represented by at least one orthologous sequence. The 
orthogroup containing Apicomplexa GNA1s clusters together with the presumed subunit H of phosphatidylinosi-
tol N-acetylglucosaminyltransferase (PIG-A subunit H, PF3D7_1141400), involved in GPI-anchor biosynthesis39. 
These two were the only orthogroups with no potential orthologs outside of Apicomplexa, including Tetrahymena 
termophila, belonging to Ciliophora, the sister phylum to Apicomplexa.
Moreover, using simple reciprocal best-hit BLAST searches between P. falciparum and human (E < 10−5), 
no potential human orthologs could be unambiguously defined for only two of the 30 P. falciparum enzymes, 
including PfGNA1 and PF3D7_0517500 (Supplementary Table S4). All together these analyses supported a rather 
exceptional evolutionary history of the Apicomplexa GNA1 family, compared to that of other enzyme families 
involved in glycoconjugate synthesis.
To further substantiate the orthologous relationships of genes belonging to the Apicomplexa GNA1 family, we 
examined their syntenic arrangements. A pairwise synteny analysis was performed by comparing the genomic 
region containing PfGNA1 in P. falciparum and 10 additional Plasmodium species, revealing series of collin-
ear genes between the two regions (Supplementary Fig. S1). Similarly, synteny was examined both within and 
between species belonging to Aconoidasida (P. falciparum and B. bovis) and Conoidasida (C. parvum, T. gondii 
and T. annulata), the two main classes in the phylum (Supplementary Fig. S2). Despite the deep evolutionary 
divergence between the two classes within the phylum (~817 MYA)40, synteny could also be observed in some 
pairwise comparisons along hundreds of Mb of genomic regions, further supporting the single and independent 
origin of the GNA1 family in Apicomplexa.
We also used the alignment of the GNAT protein domain conserved regions (resulting after removing poorly 
aligned or highly diverged regions) from the seven Apicomplexa GNA1 family sequences in Fig. 2 as a seed 
to build a Hidden Markov Model (HMM) profile. The resulting HMM profile was in turn used as a query in 
iterative searches against the UNIPROT database, with the HMM profile being iteratively rebuilt on the basis 
of the retrieved hits, ultimately resulting in the identification of a set of 50 significant protein hits exclusive to 
Figure 3. Complementation of ScGNA1-ts by PfGNA1 and other Apicomplexa orthologs. (A) S. cerevisiae 
GNA1 thermosensitive mutants GNA1-ts transformed with one of five P. falciparum candidate sequences, 
Trypanosoma brucei GNA1 (TbGNA1) or an empty MET15 vector (pRS421 pt), were grown in serial dilution on 
minimal media without uracil, methionine and cysteine (MM -ura -met -cys) at 23 °C and 37 °C. (B) GNA1-ts 
cells containing GNA1 orthologous sequences from representative apicomplexan species were cloned in pRS421 
pt and grown in serial dilution on MM -ura -met -cys at 23 °C and 37 °C. Bb, Babesia bovis; Cp, Cryptosporidium 
parvum; Et, Eimeria tenella; Tg, Toxoplasma gondii; Ta, Theileria annulata; and Gn, Gregarina niphandrodes.
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50 strains from 30 apicomplexan species. We selected a representative strain from each species, including the 
seven for which GNA1 activity was confirmed experimentally, to perform phylogenetic and sequence analyses 
(Supplementary Tables S5 and S6). Extensive diversification could be observed among lineages at the level of 
sequence length and architecture of protein motifs, reflecting the old age of the Apicomplexa clade40 (Fig. 4B). 
However, the phylogenetic relationships among sequences in the tree generally correspond well to the accepted 
taxonomic relationships among the species represented41. This observed congruence between the gene and the 
species trees is also compatible with a single evolutionary origin of the gene family.
Comparative sequence analysis between apicomplexan and non-apicomplexan GNA1 families 
further supports their independent evolutionary origin. The large superfamily of GNAT-domain 
containing proteins groups different families of enzymes that use acetyl coenzyme A (AcCoA) to transfer an 
acetyl group to a substrate30,31. Subsequent evolutionary diversification of the superfamily would have been 
shaped by extensive sequence divergence and lineage-specific domain gain and loss. Although highly divergent at 
the sequence level, GNAT domains are well-conserved in structure and catalytic mechanism26,32,33, suggesting a 
common evolutionary origin. In order to search for signatures of remote amino acid sequence homology between 
GNAT domains of the Apicomplexa GNA1 and non-apicomplexan eukaryote GNA1 enzyme families, we com-
pared the multiple sequence alignment of the conserved region of the GNAT domain in a dataset of 30 apicom-
plexan GNA1 sequences to the conserved regions of the GNAT domain from 30 GNA1 from non-apicomplexan 
eukaryote organisms, ranging from yeast to human (Supplementary Table S7). The conserved regions of the 
GNAT domain were extracted by removing poorly aligned or highly diverged regions from their respective align-
ments. The average percentage of pairwise sequence identity within the ca. 90 amino acid length alignment of api-
complexan GNA1s was 50.46% (similarity 67.71%), close to the ones observed within non-apicomplexan GNA1s 
(49.74%; similarity: 66.97%). In contrast, when apicomplexan and non-apicomplexan GNA1 sequences were 
aligned together (Supplementary Fig. S3), the average percentage of pairwise sequence identity between the two 
sets at the level of the conserved region of the GNAT domain drops to 18.06% (similarity 26.49%). The alignment 
Figure 4. Independent evolutionary origin of Apicomplexa GNA1 family. (A) The heat map represents the 
taxonomic distribution for 30 sugar nucleotide enzyme genes present in P. falciparum, i.e., the fraction of 150 
species from 12 eukaryote and prokaryote lineages containing orthologs of this gene within each taxonomic 
lineage, as inferred from the information provided in OrthoMCLDB. Orthogroups have been hierarchically 
clustered into four clusters based on the Euclidean distance between their taxonomic coverages62,67. The 
biochemical pathways they are involved in and the EC nomenclature of the enzymatic reaction catalyzed 
are indicated as colored side bars. Fir, Firmicutes; Pro, Proteobacteria; Oba, Other bacteria; Arc, Archaea; 
Eug, Euglenozoa; Amo, Amoebozoa; Vir, Viridiplantae; Tet, Tetrahymena thermophila; Api, Apicomplexa; 
Fun, Fungi; Met, Metazoa; Oeu, Other eukaryotes. See also see Table S4. (B) Phylogeny and protein domain 
architecture of putative GNA1s from 30 apicomplexan species. The Bayesian circular phylogenetic tree is drawn 
to scale, with branch lengths proportional to evolutionary distances between nodes. The tree has been rooted 
using Cryptosporidiidae representatives, considered to be occupying a basal position among Apicomplexa41. 
Values next to relevant nodes/clades indicate statistical support from maximum-likelihood, Bayesian and 
neighbor-joining phylogenetic analysis, respectively. Leaves are colored according to their taxonomic family 
membership and two additional classification groups, including class (see Table S5). Sequences examined for 
GNA1 activity are indicated in bold. The architecture in terms of conserved protein motifs detected using 
MEME is shown next to each protein (see Table S6). Outer circular lines form a protein length scale, the 
distance between lines is 100 amino acids.
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algorithm introduced a gap of 14 aa length in apicomplexan GNA1s, mostly corresponding to the B3 strand of the 
canonical motif D of the GNAT domain31.
18 aa positions in the joint alignment were found to be conserved between apicomplexan and 
non-apicomplexan GNA1s across more than 60% of the sequences (including seven and three positions con-
served in more than 75% and 90% of the sequences, respectively; Fig. 5 and Supplementary Fig. S3). Most of the 
conserved positions were found within the AcCoA binding motif A, particularly around the consensus motif 
defined for GCN5-related N-acetyltransferases31. Notably, only two of the conserved positions correspond to key 
functional residues identified in the crystal structure of human GNA1 (Fig. 5)33.
Lastly, we examined the predicted secondary structure of PfGNA1 and other apicomplexan GNA1 proteins. 
The region corresponding to the GNAT domain of PfGNA1 showed the characteristic α/β fold31, a conformation 
that was conserved across the remaining six apicomplexan GNA1s examined here (Supplementary Fig. S4). When 
compared to the secondary structure of the GNAT domain of human GNA1, obtained from its protein crystal 
structure, some degree of conservation at the structural level could be observed, in particular in motifs A and B 
at the C-terminal end of the domain. These motifs are involved in acetyl-CoA binding and the active site of the 
enzyme, respectively30,31.
In vitro activity assays of Apicomplexa GNA1 purified proteins confirm GNA1 enzymatic activity. 
To further confirm the GNA1 activity of orthologs from the Apicomplexa GNA1 family, we heterologously 
expressed and purified the corresponding proteins. The enzymes used GlcN-6P as substrate and AcCoA as donor 
to produce GlcNAc-6P, as observed by HPLC-MS/MS (Fig. 6A). Although PfGNA1 and TaGNA1 were deficiently 
expressed, they also showed residual activity as detected by HPLC-MS/MS (Supplementary Fig. S5). In addition, 
the remaining recombinant proteins demonstrated clear GNA1 activity in colorimetric assays (Supplementary 
Fig. S6).
Since CpGNA1 (cgd4_4000) has been previously described as a spermidine/spermine N1-acetyltransferase 
(SSAT), involved in the back-conversion of polyamine spermine to spermidine and putrescine in C. parvum42, 
we decided to further characterize its enzymatic activity. Kinetic analyses showed that CpGNA1 used GlcN-6P 
as substrate to generate GlcNAc-6P displaying classical Michaelis-Menten kinetics, with a Km for AcCoA of 
241.7 ± 35.3 µM and 719.1 ± 119.0 µM for GlcN-6P (Fig. S7A). In addition, in our hands CpGNA1 was not able to 
acetylate spermine or spermidine and SSAT activity could not be detected either in colorimetric (Supplementary 
Fig. S7B) or HPLC-MS/MS based assays (Fig. 6B). Furthermore, on the basis of the relative levels of GlcNAc-6P 
generated, CpGNA1 activity was not inhibited by the presence of increasing concentrations of spermine or sper-
midine (Supplementary Fig. S7C). Hence, our data clearly indicates that the primary biochemical function of 
CpGNA1 is the acetylation of GlcN-6P. Apparently, T. gondii also shows an active polyamine retroconversion 
metabolism, driven by a SSAT activity, although to our knowledge this enzyme has never been heterologously 
expressed and assayed in vitro43. Nevertheless, as in the case of CpGNA1, TgGNA1 distinctly acetylated GlcN-6P, 
Figure 5. Sequence and secondary structure of the conserved regions of the GNAT domain in apicomplexan 
and non-apicomplexan eukaryote GNA1s. Logos were generated on the basis of multiple aa sequence 
alignments of 30 non-apicomplexan eukaryote GNA1s (upper) and 30 apicomplexan GNA1s (lower) resulting 
after removing poorly aligned or highly diverged regions. Stack height indicates the information content for 
each position in the alignment, divided by the estimated probability. The residues are colored according to 
the ClustalX coloring conservation scheme. Vertical lines connect positions conserved in more than 60, 75 or 
90% of sequences in the alignments. Regions corresponding to GNAT motifs A-D of the non-apicomplexan 
eukaryote GNA1 proteins are enclosed within dashed boxes. Functional key residues and secondary structure 
as determined by the crystal structure of human glucosamine-6-phosphate N-acetyltransferase at 2.7 Å 
resolution (HsGNA1; pdb id: 3cxs) are indicated on the alignment profiles. Residues involved in binding 
GlcN-6P are shown as squares, and those contributing to the charge distribution as triangles; residues in subunit 
1 are shown as filled symbols and those from the other subunit as unfilled symbols. The predicted protein 
secondary structure for PfGNA1 is also shown. The location of the consensus motif for the GNC5-related N-
acetyltransferase family is underlined.
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and this activity was neither inhibited by spermine nor spermidine, suggesting that the function of TgGNA1 is 
indeed to acetylate GlcN-6P (Supplementary Fig. S7C).
CRISPR-Cas9-based gene disruption strongly suggests PfGNA1 is essential for parasite 
growth. Finally, to gain further insight into the biological function of PfGNA1, and to evaluate its potential as 
a drug target, we assessed whether it was required for parasite growth using CRISPR-Cas9-based techniques. In 
a first set of experiments, we attempted to disrupt PfGNA1 by CRISPR-Cas9-assisted gene truncation. Whereas 
controls using analogous plasmids targeting other regions generated viable parasites, no parasites harbouring a 
truncated version of PfGNA1 could be obtained (Fig. 7A). This suggests that the PfGNA1 gene plays an essential 
role for the survival of the parasite. In a second set of experiments, we were also unable to introduce nonsense 
mutations in the N-terminus of the GNAT domain conserved region. In contrast, in three independent biological 
replicates carried out in parallel, we successfully managed to obtain viable parasites harbouring synonymous 
nucleotide substitutions in the same region of the GNAT conserved domain (Fig. 7C). Therefore, nucleotides in 
the catalytic GNAT domain of PfGNA1 are genetically modifiable as long as the open reading frame is not altered. 
These data strongly suggest that an unaltered version of the PfGNA1 protein is required for parasite viability, at 
least during P. falciparum asexual blood stages.
Figure 6. Enzymatic activities of recombinant Apicomplexa GNA1 proteins. (A) The purified recombinant 
GNA1 enzymes were assayed in the presence of GlcN-6P and AcCoA (blue line, 25 µg/mL GNA1; red line, 
5 µg/mLGNA1; green line, no GNA1). (B) The purified recombinant CpGNA1 enzyme was assayed in the 
presence of spermine and AcCoA. Chromatograms (left panels) show the detection of an N-acetylspermine 
peak by HPLC-MS/MS in samples containing spermine (pink); AcCoA (black); AcCoA and spermine (blue); 
AcCoA, spermine and 250 µg/mL of CpGNA1 (red); AcCoA, spermine and 500 µg/mL of CpGNA1 (green); and 
AcCoA, spermine and 1000 µg/mL of CpGNA1 (grey). Nonenzymatic acetylation68 is observed in all the assays 
containing spermine and AcCoA. In these reactions, the generation of N-acetylspermine is not dependent on 
the concentration of CpGNA1, as it is shown in superimposed chromatograms (right panel).
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Discussion
Although GNA1 enzymes have been identified and characterized throughout the eukaryote kingdom, sequence 
similarity-based approaches failed to identify GNA1 genes in Apicomplexa34. This difficulty was likely due to the 
extensive divergence at the sequence level featuring the different GNAT domain-containing enzyme families with 
specific acetyl acceptor substrates and taxonomic coverages. Here, we performed a systematic classification of 
the large superfamily of GNAT domain-containing proteins in seven Apicomplexa species with fully sequenced 
genomes30,31. Our phylogenetic analysis revealed 9 well-supported gene families displaying conserved architec-
ture of protein motifs. Among them, we identified protein families containing NMT or HAT domains, includ-
ing representatives of the latter family from P. falciparum (PF3D7_0823300) and T. gondii (TGGT1_254555 and 
TGGT1_243440) that had been previously characterized44,45. We tested five P. falciparum sequences, showing no 
evident correspondence with other GNAT domain-containing gene families, by complementation assays using a 
yeast thermosensitive strain defective in GNA1. As a result, we identified PfGNA1 as able to support yeast growth 
at restrictive temperature. PfGNA1 belongs to a well-defined family containing putative orthologs in all six other 
Apicomplexa species, all of which rescued the mutant under non-permissive conditions. The GNA1 family in 
Apicomplexa appears to have had a single origin early during diversification of the phylum, an observation sup-
ported by synteny-based analysis. Furthermore, using a HMM profile based on Apicomplexa GNA1 sequences 
as a query to scan the UNIPROT database, only sequences belonging to the phylum resulted in significant hits. 
Consistently with a separate evolutionary origin of the family, the phylogenetic tree of putative GNA1 from 30 
species of Apicomplexa essentially recapitulated the accepted evolutionary relationships among the species, based 
on both ultrastructural and developmental characterizations as well as on molecular phylogenies41. Altogether, 
our results support an independent origin of the GNA1 family in Apicomplexa, which can be traced back to 
between 817 MYA (estimated time of divergence between the two main classes of the phylum) and 1344 MYA 
(estimated time of divergence between Apicomplexa and its sister group of ciliates represented by T. termophila)40.
The comparison of the GNAT domains of apicomplexan and non-apicomplexan GNA1s showed that domain 
conservation was essentially restricted to a few specific amino acid positions around the GNAT six-amino acid 
consensus motif31. Furthermore, the conserved residues were, with very few exceptions, distinct from the ones 
reported as critical for the catalytic activity of human GNA132. This observation suggests that, rather than evolv-
ing from an ancestral eukaryote GNA1 family, apicomplexan GNA1s might have evolved in parallel from a sep-
arate GNAT domain-containing gene lineage. Furthermore, considering the evolutionary time since divergence 
of the phylum from other eukaryotic lineages40, Apicomplexa-specific GNA1s may have evolved functionally 
divergent catalytic residues exploitable for the design of selective small-molecule inhibitors.
The CpGNA1 sequence (cgd4_4000) had been previously characterized to encode a SSAT42, involved in the 
reverse polyamine biosynthetic pathway in C. parvum. Here, whereas a robust GNA1 activity could be detected 
Figure 7. Genetic strategies to disrupt PfGNA1 function. (A) Diagram illustrating the strategy used for 
PfGNA1-disruption. Cas9 protein is expressed by the pUF1-Cas9 episome. pL7-GNA1 episome is continuously 
maintained using the hdhfr selection and carries simultaneously the donor DNA (homology regions: HR1/
HR2) and the sgRNA targeting PfGNA1 (pink). (B) Diagram illustrating the strategy for PfGNA1 edition. 
pDC2-Cas9-sgRNA plasmid carries the Cas9 protein and the sgRNA PfGNA1-targeting sequence together with 
the hdhfr and yfcu fusion genes for positive and negative selection, respectively. pUC19-edited gene plasmids 
carry the PfGNA1 donor sequence with shield (green star) and silent or nonsense mutations (red stars) in the 
sgRNA region generating pUC19-silentPfGNA1 or pUC19-nonsensePfGNA1, respectively. (C) Target sequence 
recognized by PfGNA1 sgRNA and chromatogram of wild-type parasites (top panel), and modified locus 
sequences and chromatogram of the edited parasites showing the shield (blue) and silent mutations (pink) 
(middle panel) and nonsense mutations (red) (bottom panel). No parasites were obtained carrying PfGNA1 
nonsense mutations. (D) Table summarizing PfGNA1 disruption attempts.
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with as low as 0.2 µg/mL of purified C. parvum protein, we did not detect a SSAT activity with up to 1000 µg/mL, 
both through colorimetric and HPLC-MS/MS based in vitro assays. In addition, neither CpGNA1 nor TgGNA143 
activities were inhibited by the presence of spermine or spermidine. Considering that the rest of the apicomplexan 
proteins tested showed evident GNA1 activities, our results suggest that the primary function of this family of 
enzymes is the acetylation of GlcN6P. Thus, the SSAT activity previously described for CpGNA1 would be resid-
ual, secondary, and/or just restricted to specific taxonomic lineages, life cycle stages or physiological conditions.
Our multiple efforts to ablate PfGNA1 using CRISPR-Cas9-based techniques were unsuccessful, despite 
evidence that the locus was genetically modifiable. This strongly suggests that the gene is essential for the 
growth of the malaria parasite, in agreement with UDP-GlcNAc being a bottleneck metabolite46, likely due 
to its involvement in the biosynthesis of important glycoconjugates, such as GPI anchors. Nevertheless, 
the relevance of GNA1 in other apicomplexan organisms is at present unknown. Notably, in a recent work, a 
loss-of-function genome-wide screen was performed in T. gondii tachyzoites to assess the contribution of tar-
geted genes to cell fitness47. With the exception of TgGNA1 (TGGT1_243600), all the genes putatively encoding 
for enzymatic activities involved in UDP-GlcNAc biosynthesis (i.e. glucosamine:fructose-6-P-amidotransferase, 
TGGT1_231350; and N-acetylglucosamine-phosphomutase, TGGT1_264650) or UDP-GlcNAc utilization (i.e. 
Phosphatidylinositol N-acetylglucosaminyltransferase, TGGT1_241860; and N-acetylglucosaminyl phosphate 
transferase, TGGT1_244520) contributed greatly to T. gondii survival. This underlines the importance of the 
amino sugar biosynthetic route, whose presence is confirmed by labelling the glycoproteins of the parasite with 
[3H]GlcN48,49. The striking lack of contribution of TgGNA1 to T. gondii fitness47 might be suggesting the existence 
of another gene in the parasite’s genome encoding for a redundant GNA1 activity, although it might also be high-
lighting certain limitations of the aforementioned study, such as the effect on proteins with slow turnover or the 
time selected for the screening readout47. Indeed, considering the comprehensive analysis of GNAT-containing 
sequences in different Apicomplexa presented here, and the functional complementation assays performed with 
additional P. falciparum sequences, no other suitable candidate sequence encoding for a redundant GNA1 activ-
ity could be identified. The generation of conditional GNA1 mutants, still a challenging task in apicomplexan 
organisms, will contribute to comprehensively define whether GNA1 biochemical activity is essential in different 
species and to confirm its suitability as a potential therapeutic target for drug development.
Methods
Sequence and phylogenetic analysis. Phylogenetic analyses were performed on the basis of multiple 
alignments of amino acid sequences obtained using MUSCLE50. Bayesian and maximum-likelihood analyses 
were carried out using the Blosum62 + G (eight categories, shape parameter: 1.87) + F protein evolution model51, 
selected by ProtTest v3.2 as the best-fitting to the data52. Bayesian analysis was implemented in MrBayes 3.2.553. 
Searches were run with four Markov chains for one million generations sampling every 100th tree. After the 
stationary phase was reached, determined by the average standard deviation of split sequences approaching 0 
(<0.05), the first 2,500 trees were discarded as burn-in. A consensus tree was then constructed to evaluate poste-
rior probabilities on clades. Maximum-likelihood trees were constructed using PhyML v3.1, with tree topology 
searching optimized using the subtree pruning and regrafting option54. The statistical support of the retrieved 
topology was assessed using the Shimodaira-Hasegawa-like approximate likelihood ratio test55. Neighbor-joining 
phylogenetic analyses were conducted in Seaview v4.5.456, with statistical support on clades assessed using a 
bootstrap analysis with 1,000 replicates. Trees were represented and edited using iTOL v3.3.257. MEME v4.11.2 
was used to identify conserved motifs shared among proteins58. Profile hidden Markov models (HMMs) were 
generated and calibrated using HMMER v3.059, on the basis of MUSCLE protein alignments50 further edited with 
Gblocks60. Logo representations of multiple protein sequence alignments were obtained using Skylign61. Protein 
secondary structures for apicomplexan GNA1 sequences were predicted using SABLE62.
Cloning of apicomplexan GNA1 candidate sequences. pRS421 vector (ATCC 87475), containing 
ampicillin and MET1563, was modified by cloning S. cerevisiae GPD promoter and CYC1 terminator sequences 
using SacII/BamHI and XhoI/KpnI restriction sites. The new vector generated, pRS421 pt was used to clone dif-
ferent GNA1 candidate sequences. Genomic DNAs of C. parvum, E. tenella, T. gondii, and T. brucei were used as 
templates for PCR amplification with Platinum DNA Polymerase High Fidelity (Thermo Scientific), using specific 
primers including BamHI and XhoI restriction sites (Supplementary Table S8). The remaining sequences cloned 
in pRS421 pt were codon-optimized synthetic genes (GenScript or Integrated DNA Technologies) based on the 
predicted amino acid sequences.
Yeast complementation assays. A S. cerevisiae GNA1 thermosensitive mutant, ScGNA1-ts38, was used 
for GNA1 complementation assays. The mutant contains a temperature-sensitive copy of GNA1 (YFL017C), 
which encodes a GNA1 enzymatic activity essential for yeast survival. The thermosensitive allele is marked by 
URA3 and the mutant was not able to grow above 34 °C38. ScGNA1-ts contains also a mutated MET15 gene that 
allows auxotrophic complementation with pRS421 pt vector in minimal media without uracil, methionine and 
cysteine (-ura, -met, -cys). After transformation with pRS421 pt based constructs, yeast cells were grown in serial 
dilution at permissive (23 °C) and restrictive (37 °C) temperatures.
Apicomplexan GNA1 protein expression and purification. Codon-optimized versions of apicompl-
exan GNA1 (PfGNA1, BbGNA1, CpGNA1, EtGNA1, TgGNA1, TaGNA1, and GnGNA1) native sequences were 
cloned in a pGEX 6P-1 vector containing an N-terminal glutathione S-transferase (GST) tag and transformed 
in E. coli BL21 (DE3). Cultures were grown for 16 h at 30 °C after induction, lysed and supernatants contain-
ing the glutathione S-transferase (GST)-tagged GNA1 protein were filtered and purified through GSTrap HP 
1-ml or GST SpinTrap columns (GE Healthcare). The proteins of interest were then dialyzed (Thermo Scientific 
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Slide-A-Lyzer MINI Dialysis Devices, 10 K MWCO) at 4 °C using Buffer A (50 mM Tris-HCl pH 7.5; 250 mM 
NaCl) and stored.
GNA1 and SSAT in vitro assays. GNA1 activity was assayed using 500 µM of AcCoA, 500 µM of GlcN-6P 
and different concentrations of apicomplexan GNA1 in 50 µl of 25 mM Tris-HCl–150 mM NaCl, pH 7.2 solution. 
To determine SSAT activity the same protocol was used but using as substrate 500 µM of spermine and 3 different 
CpGNA1 concentrations (250 µg/ml, 500 µg/ml and 1000 µg/ml). For SSAT colorimetric assays 500 µM of sper-
mine or spermidine were used as substrate and 1, 20 or 500 µg/ml of CpGNA1. Reactions were allowed to proceed 
for 30 min at room temperature before being stopped by boiling for 10 min.
Liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-MS/MS). 
LC-MS/MS analyses were carried out on an UPLC – Acquity system (Waters) coupled by electrospray ionization 
to an API3000 triple quadrupole LC-MS/MS mass spectrometer (Perkin-Elmer Sciex), using a Kinetex® 2.6 µm 
HILIC 100 Å column (150 × 4.6 mm, Phenomenex) for Glc-6P/GlcNAc-6P detection, and a an XBridge HILIC 
5.0 µm, 130 Å (150 × 4.6 mm, Waters) for spermine/N-acetylspermine detection (see Supplementary Methods).
CRISPR-Cas9 PfGNA1-disruption and PfGNA1-editing constructs. Parasites were cultured and 
transfected either by electroporating ring-stage parasites or by nucleofection of schizont stages, as previously 
described64. All the methods were carried out in accordance with relevant guidelines and regulations and human 
erythrocytes and serum were purchased from the Banc de Sang i Teixits (Catalonia, Spain), after ethical approval 
from the Comitè Ètic Investigació Clínica Hospital Clínic de Barcelona. A single guide RNA (sgRNA) targeting 
the PfGNA1 consensus motif [(R/Q)-X-X-Q-X-G] was chosen using the Eukaryotic Pathogen CRISPR gRNA 
Design Tool65. For PfGNA1-disruption homology regions (HR) 1 and 2 were amplified from 3D7 P. falciparum 
genomic DNA using primers P1/P2 and P3/P4 and cloned in plasmid pL7 using SpeI/AflII and EcoRI/NcoI 
restriction sites, respectively64. sgRNA was integrated replacing pL7 BtgZI-adaptor (Fig. 7A). For PfGNA1 edi-
tion, sgRNA and Cas9-expressing construct (pDC2-Cas9-hDHFRyFCU)66 and linearized pUC19 plasmids were 
used as backbone. The sgRNA sequence was cloned in the pDC2-Cas9-sgRNA using primers P5/P6. PfGNA1 
coding sequences with a shield mutation in the protospacer-adjacent motif (PAM)64 and silent or nonsense muta-
tions were cloned in pUC19 to generate pUC19-silent PfGNA1 or pUC19-nonsense PfGNA1 (Fig. 7B). All prim-
ers used are described in Supplementary Table S8.
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